A Comprehensive Review on Synergy of Multi-Modal Data and AI Technologies in Medical Diagnosis
- PMID: 38534493
- PMCID: PMC10967767
- DOI: 10.3390/bioengineering11030219
A Comprehensive Review on Synergy of Multi-Modal Data and AI Technologies in Medical Diagnosis
Abstract
Disease diagnosis represents a critical and arduous endeavor within the medical field. Artificial intelligence (AI) techniques, spanning from machine learning and deep learning to large model paradigms, stand poised to significantly augment physicians in rendering more evidence-based decisions, thus presenting a pioneering solution for clinical practice. Traditionally, the amalgamation of diverse medical data modalities (e.g., image, text, speech, genetic data, physiological signals) is imperative to facilitate a comprehensive disease analysis, a topic of burgeoning interest among both researchers and clinicians in recent times. Hence, there exists a pressing need to synthesize the latest strides in multi-modal data and AI technologies in the realm of medical diagnosis. In this paper, we narrow our focus to five specific disorders (Alzheimer's disease, breast cancer, depression, heart disease, epilepsy), elucidating advanced endeavors in their diagnosis and treatment through the lens of artificial intelligence. Our survey not only delineates detailed diagnostic methodologies across varying modalities but also underscores commonly utilized public datasets, the intricacies of feature engineering, prevalent classification models, and envisaged challenges for future endeavors. In essence, our research endeavors to contribute to the advancement of diagnostic methodologies, furnishing invaluable insights for clinical decision making.
Keywords: artificial intelligence; deep learning; disease diagnosis; large model; machine learning; multi-modal data.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Advances and prospects of multi-modal ophthalmic artificial intelligence based on deep learning: a review.Eye Vis (Lond). 2024 Oct 1;11(1):38. doi: 10.1186/s40662-024-00405-1. Eye Vis (Lond). 2024. PMID: 39350240 Free PMC article. Review.
-
Artificial intelligence (AI) for medical imaging to combat coronavirus disease (COVID-19): a detailed review with direction for future research.Artif Intell Rev. 2022;55(2):1409-1439. doi: 10.1007/s10462-021-09985-z. Epub 2021 Apr 15. Artif Intell Rev. 2022. PMID: 33875900 Free PMC article.
-
Empowering Modern Dentistry: The Impact of Artificial Intelligence on Patient Care and Clinical Decision Making.Diagnostics (Basel). 2024 Jun 14;14(12):1260. doi: 10.3390/diagnostics14121260. Diagnostics (Basel). 2024. PMID: 38928675 Free PMC article. Review.
-
Application of Artificial Intelligence in Neuroendocrine Lung Cancer Diagnosis and Treatment: A Systematic Review.Cureus. 2024 May 24;16(5):e61012. doi: 10.7759/cureus.61012. eCollection 2024 May. Cureus. 2024. PMID: 38910787 Free PMC article. Review.
-
AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling.Ageing Res Rev. 2024 Nov;101:102497. doi: 10.1016/j.arr.2024.102497. Epub 2024 Sep 16. Ageing Res Rev. 2024. PMID: 39293530 Review.
Cited by
-
The Role of Artificial Intelligence in the Diagnosis and Management of Non-convulsive Seizures: A Narrative Review.Cureus. 2025 Feb 21;17(2):e79409. doi: 10.7759/cureus.79409. eCollection 2025 Feb. Cureus. 2025. PMID: 40130106 Free PMC article. Review.
-
Closing Editorial: Advancements in Artificial Intelligence for Dentomaxillofacial Radiology-Current Trends and Future Directions.Diagnostics (Basel). 2025 May 13;15(10):1222. doi: 10.3390/diagnostics15101222. Diagnostics (Basel). 2025. PMID: 40428215 Free PMC article.
-
Longitudinal big biological data in the AI era.Mol Syst Biol. 2025 Aug 5. doi: 10.1038/s44320-025-00134-0. Online ahead of print. Mol Syst Biol. 2025. PMID: 40764831 Review.
-
Advancements in deep learning for early diagnosis of Alzheimer's disease using multimodal neuroimaging: challenges and future directions.Front Neuroinform. 2025 May 2;19:1557177. doi: 10.3389/fninf.2025.1557177. eCollection 2025. Front Neuroinform. 2025. PMID: 40385089 Free PMC article. Review.
-
Advancing Alzheimer's Therapy: Computational strategies and treatment innovations.IBRO Neurosci Rep. 2025 Feb 4;18:270-282. doi: 10.1016/j.ibneur.2025.02.002. eCollection 2025 Jun. IBRO Neurosci Rep. 2025. PMID: 39995567 Free PMC article. Review.
References
-
- Anto S., Chandramathi S. Supervised machine learning approaches for medical data set classification—A review. Int. J. Comput. Sci. Trends Technol. 2011;2:234–240.
-
- Allen N., Sudlow C., Downey P., Peakman T., Danesh J., Elliott P., Gallacher J., Green J., Matthews P., Pell J., et al. UK Biobank: Current status and what it means for epidemiology. Health Policy Technol. 2012;1:123–126. doi: 10.1016/j.hlpt.2012.07.003. - DOI
-
- Sudlow C., Gallacher J., Allen N., Beral V., Burton P., Danesh J., Downey P., Elliott P., Green J., Landray M., et al. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779. doi: 10.1371/journal.pmed.1001779. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources